Literature DB >> 6166712

Antigen-inducible, H-2-restricted, interleukin-2-producing T cell hybridomas. Lack of independent antigen and H-2 recognition.

J W Kappler, B Skidmore, J White, P Marrack.   

Abstract

We developed a method for production of antigen-specific, H-2-restricted T cell hybrids. The tumor cell partner in the fusions was itself a T cell hybrid, FS6-14.13.AG2 (or its derivatives), which could be induced to produce the growth factor, interleukin-2 (IL-2), in response to a challenge with concanavalin A, but had no known antigen specificity. The normal T cell partner in the fusions was a population of lymph node T cell blasts that had been highly enriched in antigen-specific, H-2-restricted T cells by in vivo immunization, followed by in vitro challenge with antigen and clonal expansion in IL-2-containing medium. These fusions produced hybrids that grew constitutively in culture. A sizable proportion of the hybrids demonstrated the ability to produce IL-2 in response to a challenge with specific antigen presented by irradiated spleen cells of the appropriate H-2 type. Four cloned antigen/H-2-specific hybrid lines were produced. AO-40.10 responded to chicken ovalbumin (OVA) when presented by I-A(k)-bearing cells. DC1.18.3 responded to the apo form of beef cytochrome c when presented with I-A(d). AODK-10.4 responded to keyhole limpet hemocyanin (KLH) presented with I-A (d). AODK-1.16 also responded to KLH presented by a product of the I region of H-2(d), but the data were consistent with either a product of the I-J-I-E(d) region or a combinatorial molecule with elements from both I-A(d) and I-E(d)/I-C(d). Coincidentally, AO-40.10 was shown to have an unexpected alloreactivity with a product of H-2(b) mapping to the K-I-A region. These hybrids should prove invaluable as sources of monoclonal material for the study of the receptor(s) on T cells with H-2-restricted antigen specificities. We also generated T cell hybrids with two antigen/H-2 specificities by fusing an azaguanine-resistant clone of AO-40.10 to normal T cells with a different antigen/H-2 specificity. Many of the hybrids retained reactivity to OVA plus H-2(a) and to the second antigen/H-2 combination. None reacted to either OVA plus the second H-2 type or to the second antigen plus H-2(a). One of these hybrids was successfully cloned to produce the line AOFK- 11.11.1. It retained the ability to recognize OVA plus I-A(k) inherited from one parent, and KLH plus IA(f) inherited from the other. It did not recognize OVA plus IA(f) or KLH plus I-A(k). These results have some bearing on models describing the nature of T cell receptors for antigen recognized in association with H-2 products. They do not support models in which antigen and H-2 are recognized separately by two independent T cell receptors.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6166712      PMCID: PMC2186156          DOI: 10.1084/jem.153.5.1198

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  40 in total

1.  T-cell lines producing antigen-specific suppressor factor.

Authors:  S Kontiainen; E Simpson; E Bohrer; P C Beverley; L A Herzenberg; W C Fitzpatrick; P Vogt; A Torano; I F McKenzie; M Feldmann
Journal:  Nature       Date:  1978-08-03       Impact factor: 49.962

2.  T-cell inhibition of humoral responsiveness. II. Theory on the role of restrictive recognition in immune regulation.

Authors:  M Cohn; R Epstein
Journal:  Cell Immunol       Date:  1978-08       Impact factor: 4.868

Review 3.  Cell-mediated immunity and the major histocompatibility complex.

Authors:  R E Langman
Journal:  Rev Physiol Biochem Pharmacol       Date:  1978       Impact factor: 5.545

4.  Properties of monoclonal antibodies to mouse Ig allotypes, H-2, and Ia antigens.

Authors:  V T Oi; P P Jones; J W Goding; L A Herzenberg; L A Herzenberg
Journal:  Curr Top Microbiol Immunol       Date:  1978       Impact factor: 4.291

5.  Major histocompatibility complex-linked immune-responsiveness is acquired by lymphocytes of low-responder mice differentiating in thymus of high-responder mice.

Authors:  H von Boehmer; W Haas; N K Jerne
Journal:  Proc Natl Acad Sci U S A       Date:  1978-05       Impact factor: 11.205

Review 6.  Major transplantation antigens, viruses, and specificity of surveillance T cells.

Authors:  R M Zinkernagel; P C Doherty
Journal:  Contemp Top Immunobiol       Date:  1977

7.  A dual recognition model for cytotoxic T cells based on thymic selection of precursors with low affinity for Self H-2 antigens.

Authors:  R V Blanden; G L Ada
Journal:  Scand J Immunol       Date:  1978-03       Impact factor: 3.487

8.  Lymphocyte specificity to protein antigens. I. Characterization of the antigen-induced in vitro T cell-dependent proliferative response with lymph node cells from primed mice.

Authors:  G Corradin; H M Etlinger; J M Chiller
Journal:  J Immunol       Date:  1977-09       Impact factor: 5.422

9.  Restricted helper function of F1 hybrid T cells positively selected to heterologous erythrocytes in irradiated parental strain mice. II. Evidence for restrictions affecting helper cell induction and T-B collaboration, both mapping to the K-end of the H-2 complex.

Authors:  J Sprent
Journal:  J Exp Med       Date:  1978-04-01       Impact factor: 14.307

10.  On the thymus in the differentiation of "H-2 self-recognition" by T cells: evidence for dual recognition?

Authors:  R M Zinkernagel; G N Callahan; A Althage; S Cooper; P A Klein; J Klein
Journal:  J Exp Med       Date:  1978-03-01       Impact factor: 14.307

View more
  348 in total

1.  An inverse relationship between T cell receptor affinity and antigen dose during CD4(+) T cell responses in vivo and in vitro.

Authors:  W Rees; J Bender; T K Teague; R M Kedl; F Crawford; P Marrack; J Kappler
Journal:  Proc Natl Acad Sci U S A       Date:  1999-08-17       Impact factor: 11.205

2.  Natural killer 1.1(+) alpha beta T cells in the periimplantation uterus.

Authors:  Y Dang; J Beckers; C R Wang; K D Heyborne
Journal:  Immunology       Date:  2000-12       Impact factor: 7.397

3.  Localization of CD4+ T cell epitope hotspots to exposed strands of HIV envelope glycoprotein suggests structural influences on antigen processing.

Authors:  S Surman; T D Lockey; K S Slobod; B Jones; J M Riberdy; S W White; P C Doherty; J L Hurwitz
Journal:  Proc Natl Acad Sci U S A       Date:  2001-04-03       Impact factor: 11.205

4.  Abundant empty class II MHC molecules on the surface of immature dendritic cells.

Authors:  L Santambrogio; A K Sato; F R Fischer; M E Dorf; L J Stern
Journal:  Proc Natl Acad Sci U S A       Date:  1999-12-21       Impact factor: 11.205

5.  Latent antigen vaccination in a model gammaherpesvirus infection.

Authors:  E J Usherwood; K A Ward; M A Blackman; J P Stewart; D L Woodland
Journal:  J Virol       Date:  2001-09       Impact factor: 5.103

6.  Diabetogenic T cells recognize insulin bound to IAg7 in an unexpected, weakly binding register.

Authors:  Brian D Stadinski; Li Zhang; Frances Crawford; Philippa Marrack; George S Eisenbarth; John W Kappler
Journal:  Proc Natl Acad Sci U S A       Date:  2010-06-01       Impact factor: 11.205

7.  Non-random lymphocyte distribution among virus-infected cells of the respiratory tract.

Authors:  Rajeev Rudraraju; Robert E Sealy; Sherri L Surman; Paul G Thomas; Barry H Dayton; Julia L Hurwitz
Journal:  Viral Immunol       Date:  2013-12       Impact factor: 2.257

8.  Prevention of diabetes in nonobese diabetic mice by anti-I-A monoclonal antibodies: transfer of protection by splenic T cells.

Authors:  C Boitard; A Bendelac; M F Richard; C Carnaud; J F Bach
Journal:  Proc Natl Acad Sci U S A       Date:  1988-12       Impact factor: 11.205

9.  The role of autoreactive T-cell hybridomas from autoimmune model mice.

Authors:  S Yanoma; I Aoki; N Ishii; K Tani; C S David; K Okuda
Journal:  Immunology       Date:  1988-05       Impact factor: 7.397

10.  Antigen-reactivity pattern of T-cell hybridomas from Mycobacterium bovis BCG-infected mice.

Authors:  I Müller; S H Kaufmann
Journal:  Infect Immun       Date:  1985-09       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.